| URL | https://endpts.com/vor-bio-opts-to-keep-manufactur |
| Source | ENDPOINTS NEWS |
| Date Published | 09/29/2022 |
| Author Name | Tyler Patchen |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Vor Biopharma |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2022 |
| City reshored to: | Cambridge |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | hematopoietic stem cells (eHSCs), CAR-T therapies |
| What domestic positive factors made reshoring more attractive? | Skilled workforce availability/training |